High 25-hydroxyvitamin D is associated with unexpectedly high plasma inflammatory markers in HIV patients on antiretroviral therapy.

Gangcuangco LMA, Kohorn LB, Chow DC, Keating SM, Norris PJ, Nagamine LS, Ndhlovu LC, Souza SA, Kallianpur KJ, Shikuma CM. High 25-hydroxyvitamin D is associated with unexpectedly high plasma inflammatory markers in HIV patients on antiretroviral therapy. Medicine (Baltimore). 2016 Oct; 95(43):e5270.

View in: PubMed

subject areas

Adult
Anti-Retroviral Agents
Cross-Sectional Studies
Cytokines
Female
HIV Infections
Humans
Inflammation
Male
Middle Aged
Risk Factors
Vitamin D

authors with profiles

Kalpana Kallianpur, PhD
Dominic Chow, MD, PhD, MPH
Cecilia M. Shikuma,MD
Lishomwa Ndhlovu, MD PhD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support